You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3976 to 4000 of about 5882
Next 25
05/03/2007
Ladies of Legacy, a non-profit foundation dedicated to financial support of brain and spinal cord tumor patients, presents the second annual `Celebration of Life` event Sunday, May 6th, 2007 at 1 pm at the Warwick Melrose Hotel in Dallas.
05/02/2007
New vaccine therapy + Poly ICLC for recurrent malingant gliomas
04/29/2007
New mechanism identified for resistance to targeted lung cancer drugs
04/26/2007
Brain Tumors: Confronting the Challenge Together - June 16 in NY
04/24/2007
Pharmacyclics Announces FDA Filing of New Drug Application for Xcytrin(R) Injection to Treat Lung Cancer Brain Metastases
04/22/2007
Updated David Bailey`s survivor story!
Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients.
Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells.
04/20/2007
Added: CDX-110 to list of brain tumor treatments
Malignant Glioma Cells Counteract Antitumor Immune Responses through Expression of Lectin-Like Transcript-1.
Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.
AstraZeneca brain tumor drug shows promise
Antiangiogenic Agent Shows Promise against Glioblastoma
Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib.
New vaccine trial for newly diagnosed glioblastoma multiforme
No Generic Substitution of AEDs (anti seizure drugs) Without Physician and Patient Consent, Says AAN
04/19/2007
Race for Hope - Washington, DC May 6, 2007
Data From Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting
04/18/2007
A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors.
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.
Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.
Gamma knife surgery for focal brainstem gliomas.